An Affordable Two-Test Solution for HIV, Syphilis and Hepatitis B Screening
New York, 21 September 2026 — Premier Medical Corporation Private Limited (PMC) today announced the launch of its Triple Elimination Testing Bundle, a new commercial offering designed to make screening for HIV, syphilis and hepatitis B more affordable and accessible across low- and middle-income countries. The bundle combines two rapid diagnostic tests:

Together, these two tests provide screening coverage for three important infections and are designed to integrate into existing antenatal care systems and established testing workflows. Developed through a market recalibration approach, the Triple Elimination Testing Bundle has been shaped around country needs, affordability and practical implementation requirements. The offering also includes access to digital training, assessment and competency tools for end users, supporting effective deployment of point-of-care testing.

“At Premier Medical Corporation, we believe equitable access to healthcare is a fundamental human right. The Triple Elimination Testing Bundle is a practical step towards making that right a reality, offering screening for HIV, syphilis and hepatitis B at US$1 per woman through existing antenatal systems.”

— Dr. Aatish Madhiwala
President & Chief Medical Officer
Premier Medical Corporation Private Limited

Interested in the US$1 Triple Elimination Testing Bundle?
The offering is available for:
Governments | Procurement Agencies | Implementing Partners | Private-Sector Purchasers
Contact Premier Medical Corporation to discuss volumes, supply requirements and ordering.
Email: info@premiermedcorp.com
Website: www.premiermedcorp.com